









Markets
/
Stocks
/
nasdaq-mlab
/

Mesa Laboratories Inc

MLAB

82.070USD

0.0000.00%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

269.27MMarket Cap

124.87P/E TTM



Mesa Laboratories Inc

82.070

0.0000.00%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Mesa Laboratories Inc

Currency: USD Updated: 2026-03-27

Key Insights

Mesa Laboratories Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 49 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 104.50.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Mesa Laboratories Inc's Score

Industry at a Glance

Industry Ranking

49 / 208

Overall Ranking

146 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive

Mesa Laboratories Inc Highlights

StrengthsRisks

Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.

Overvalued

The company’s latest PE is 124.87, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 4.73M shares, decreasing 17.91% quarter-over-quarter.

Held by HOTCHKIS & WILEY

Star Investor HOTCHKIS & WILEY holds 2.90K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 1.06.

Analyst Rating

Based on 3 analysts

Buy

Current Rating

104.500

Target Price

+27.83%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of Mesa Laboratories Inc is 8.55, ranking 26 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 65.13M, representing a year-over-year increase of 3.64%, while its net profit experienced a year-over-year increase of 316.59%.

Score

Industry at a Glance

Previous score

8.55

Change



Financials

6.51

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

10.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.76

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.14

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.33

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Mesa Laboratories Inc's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of Mesa Laboratories Inc is 6.21, ranking 167 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 124.87, which is 744.65% below the recent high of 1054.75 and 803.20% above the recent low of -878.12.

Score

Industry at a Glance

Previous score

6.21

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 49/208

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of Mesa Laboratories Inc is 7.33, ranking 134 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 95.00, with a high of 115.00 and a low of 75.00.

Score

Industry at a Glance

Previous score

7.33

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 3 analysts

Buy

Current Rating

104.500

Target Price

+27.83%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

115

Total

Median

Average

Company name

Ratings

Analysts

Mesa Laboratories Inc

MLAB

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of Mesa Laboratories Inc is 6.99, ranking 41 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 95.05 and the support level at 70.08, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.98

Change

0.01

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.322

Neutral

RSI(14)

46.641

Neutral

STOCH(KDJ)(9,3,3)

61.251

Neutral

ATR(14)

4.657

Low Volatility

CCI(14)

67.264

Neutral

Williams %R

26.560

Buy

TRIX(12,20)

-0.451

Sell

StochRSI(14)

46.367

Sell

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

82.190

Sell

MA10

81.447

Buy

MA20

83.193

Sell

MA50

86.388

Sell

MA100

82.566

Sell

MA200

79.098

Buy

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Mesa Laboratories Inc is 7.00, ranking 81 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 85.53%, representing a quarter-over-quarter decrease of 7.79%. The largest institutional shareholder is The Vanguard, holding a total of 321.90K shares, representing 5.83% of shares outstanding, with 17.07% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

327.65K

-53.77%

The Vanguard Group, Inc.

Star Investors

321.72K

-17.10%

Boston Partners

114.36K

+2009.52%

Select Equity Group, L.P.

126.72K

+23.99%

Ranger Investment Management, L.P.

209.70K

-2.14%

Geneva Capital Management LLC

191.39K

-3.87%

Royce Investment Partners

Star Investors

148.56K

-40.00%

Owens (Gary M)

148.26K

+8.45%

Kennedy Capital Management LLC

121.55K

+34.34%

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Mesa Laboratories Inc is 5.99, ranking 68 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.93. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Mesa Laboratories Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.